Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Get coverage of the latest pharmaceutical business developments, and historical metrics on financing, licensing, partnership, and acquisition.
Our trusted Pharma Intelligence brands
Biomedtracker
22 Feb 2019
A Review of Select Catalysts from Last Quarter’s Outlook Report.
Topic Clinical trials Drug approval Drug review Drug development landscape
Pink Sheet
22 Feb 2019
By partnering with the Pink Sheet. Pink Sheet is the world’s premier provider of compliance, legislation, policy regulation and industry developments for biopharma decision makers, arming subscribers with the critical information they rely on daily to implement their strategies.
Topic BioPharmaceutical
Biomedtracker, Meddevicetracker
22 Feb 2019
In this report, we cover catalysts from 23 drugs, devices and diagnostics expected to occur in early 2019.
Topic Drug approval Drug review Medtech
In Vivo
22 Feb 2019
No NASH treatments are on the market yet, but Phase III data readouts are emerging, mid-stage drugs are demonstrating their capabilities and combinations are in view.
Topic Clinical trials
Pink Sheet
By Francesca Bruce 22 Feb 2019
Regulatory harmonization is gathering pace in Latin America, which is good news for pharmaceutical companies.
Topic Policy and regulation
Medtech Insight
By Amanda Maxwell 22 Feb 2019
Efforts are underway by EU notified body groups to encourage a uniform interpretation of the EU MDR when it comes to the risk classification of spinal implants. Their work could also reduce the amount of unnecessary notified body and expert panel work on some implantable devices.
Topic Medtech
Medtech Insight
By Marion Webb 22 Feb 2019
The global market for bone densitometers and bone turnover markers will reach $373.1m by 2023, driven in large part by the rising aging population and rising prevalence of osteoporosis.
Topic Medtech
Scrip
By Emily Hayes 21 Feb 2019
Analyst speculates that risk of pulmonary embolism for a higher unapproved of Xeljanz in arthritis could trigger a label change for the same regimen in the drug's ulcerative colitis indication.
Topic Arthritis
Scrip
By Kevin Grogan 21 Feb 2019
When buying Loxo, Lilly highlighted the importance of LOXO-292, a first-in-class oral RET inhibitor, rather than the already-approved Vitrakvi, perhaps knowing that partner Bayer was going to be exercising an option to take full control of the TRK inhibitor.
Scrip, Pink Sheet
By Mary Jo Laffler 19 Feb 2019
The data and analysis for this webinar were drawn from Pink Sheet and Scrip, both part of the Informa Pharma Intelligence suite of intelligence solutions.
HBW Insight
14 Feb 2019
France's self-medication market had a difficult 2018, due to a weak flu season and changing dynamics in the sector, according to industry association Afipa. Despite this it was a good year for Sanofi, which overtook Boiron as the number-one OTC firm in the market, while its Doliprane analgesic became France's best-selling brand.
Topic Drug review
Generics Bulletin
14 Feb 2019
Alvogen is claiming the first European launch of a generic rival to Revlimid, rolling out the oncology drug in several central and eastern European markets. Meanwhile, IPR challenges to three Revlimid patents in the US have been denied.
Topic Drug review
Pink Sheet
By Michael McCaughan 14 Feb 2019
Here is what to expect from – and some free advice for – seven industry executives as they prepare for a hearing on drug pricing in the Senate Finance Committee.
Topic Drug approval
Medtech Insight
By Ferdous Al-Faruque 14 Feb 2019
Despite a recent report that Sen. Amy Klobuchar, D-Minn., is backing away from leading efforts to repeal the medical device tax due to her presidential ambitions, sources say she is working with Sen. Pat Toomey, R-Pa., to cosponsor a repeal bill this year. Similarly, on the US House-side, Rep. Ron Kind, D-Wisc., is calling on his colleagues to support a full repeal bill as well.
Topic Medtech
Medtech Insight
By Ashley Yeo 14 Feb 2019
The EU Medical Device Regulation is 15 months away from being implemented in full, and a new German survey about its potential impact on the medtech innovation and patient-care landscape makes for sobering reading.
Topic Medtech
Scrip
22 Feb 2019
Scrip
22 Feb 2019
Pink Sheet
22 Feb 2019
Medtech Insight
22 Feb 2019
Medtech Insight
22 Feb 2019
Medtech Insight
22 Feb 2019
Medtech Insight
22 Feb 2019
Medtech Insight
22 Feb 2019
Medtech Insight
22 Feb 2019
Pink Sheet
22 Feb 2019
Medtech Insight
22 Feb 2019
Medtech Insight
22 Feb 2019
Scrip
22 Feb 2019
Medtech Insight
21 Feb 2019
Pink Sheet
21 Feb 2019
Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.
Key benefits:
Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.
Key benefits:
Key benefits:
28 Feb 2019 , 16:00 GMT
Webinar
03 Mar 2019 , 08:00 CST
Texas , USA
Industry conference
07 Mar 2019 , 09:00 GMT
UK
Awards
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
Keep up to date